MedTrace Logo

Standard Post Market Clinical Follow-up (PMCF) Study WSA 2025

NCT06986499 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-05-23

No results posted yet for this study

Summary

The purpose of the study is to follow-up on a released low-risk device as part of standard PMCF activities.

Conditions

  • Hearing Loss, Sensorineural

Interventions

DEVICE

Hearing Aid Widex SmartRIC MRRLD 440

Receiver in Canal (RIC) hearing aid

DEVICE

Own hearing aid

subjects' own hearing aids, any brand, any model

Sponsors & Collaborators

  • Hoerzentrum Oldenburg

    collaborator UNKNOWN

  • WSAUD A/S

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-25
Primary Completion
2025-04-23
Completion
2025-05-09

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06986499 on ClinicalTrials.gov